Compression Stockings for Treating Vasovagal Syncope Trial

NCT05086679 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 268

Last updated 2022-04-15

No results posted yet for this study

Summary

Syncope, a sudden, transient loss of consciousness (TLOC), is a common inconvenience of daily function and quality of life (QoL). The vasovagal syncope (VVS) is the most common type of syncope, which central and peripheral stimuli may trigger syncope by decreasing peripheral vascular resistance, bradycardia, or both. The venous return to the heart is one of these triggers which its reduction may occur due to prolonged standing, hot environment, hypovolemia, or redistribution of blood volume. The compression stockings may reduce syncopal episodes by increasing venous return. Although the use of compression stockings was never assessed in clinical trials, it could be a possible treatment for decreasing VVS recurrences.

Conditions

  • Syncope, Vasovagal

Interventions

DEVICE

Compression Stockings with 25-30 mm Hg pressure

The group will have compression stockings with 25-30 mm Hg pressure. All the participants' size for compression stocking will be measured at the first visit. Three points will be measured: below and above their knees and above their ankle. Subsequently, Right Arian Farmed Co (Tehran, Iran) will provide compression stockings for patients based on their sizes. Participants will be asked to use compression stockings as long as they could (ideal would be the majority of the time they are upright). In addition, a CD included some videos and booklets about instructions on how to wear CS and how to keep them will be provided for the participants with their compression stockings.

DEVICE

Compression stockings with up to <=10 mm Hg pressure

The group will have compression stockings with up to 10 mm Hg pressure. All the participants' size for compression stocking will be measured at the first visit. Three points will be measured: below and above their knees and above their ankle. Subsequently, Right Arian Farmed Co (Tehran, Iran) will provide compression stockings for patients based on their sizes. Participants will be asked to use compression stockings as long as they could (ideal would be the majority of the time they are upright). In addition, a CD included some videos and booklets about instructions on how to wear CS and how to keep them will be provided for the participants with their compression stockings.

BEHAVIORAL

Lifestyle modification

All patients will receive standard treatment of VVS despite their randomization(drink 2-3 liters of fluids, consume 10 grams 120 mmol/day of sodium chloride, and practice counter-pressure maneuvers (squatting, leg crossing, handgrip, and arm-tensing))

Sponsors & Collaborators

  • Tehran Arrhythmia Center

    collaborator UNKNOWN
  • Rajaie Cardiovascular Medical and Research Center

    collaborator OTHER
  • Imam Khomeini Hospital

    collaborator OTHER
  • Isfahan University of Medical Sciences

    collaborator OTHER
  • Ahvaz Jundishapur University of Medical Sciences

    collaborator OTHER
  • Guilan University of Medical Sciences

    collaborator OTHER
  • Tehran Heart Center

    lead OTHER

Principal Investigators

  • Hamed Tavolinejad, MD · Tehran Heart Center, Tehran University of Medical Sciences

  • Amirhossein Poopak, MD · Tehran Heart Center, Tehran University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-03-14
Primary Completion
2024-10-10
Completion
2024-12-10

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05086679 on ClinicalTrials.gov